NCT01165476View on ClinicalTrials.gov

Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Treprostinil diethanolamine

sustained release tablets. One 1mg tablet per period. Two total doses.

Trial Locations (1)

78744

PPD Development, Austin

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY